Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2011 2
2013 2
2014 2
2015 8
2016 16
2017 14
2018 16
2019 18
2020 22
2021 19
2022 33
2023 19
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31253744

143 results

Results by year

Filters applied: . Clear all
Page 1
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.
Kiess AP, Minn I, Vaidyanathan G, Hobbs RF, Josefsson A, Shen C, Brummet M, Chen Y, Choi J, Koumarianou E, Baidoo K, Brechbiel MW, Mease RC, Sgouros G, Zalutsky MR, Pomper MG. Kiess AP, et al. J Nucl Med. 2016 Oct;57(10):1569-1575. doi: 10.2967/jnumed.116.174300. Epub 2016 May 26. J Nucl Med. 2016. PMID: 27230930 Free PMC article.
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.
Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG. Banerjee SR, et al. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2545-2557. doi: 10.1007/s00259-019-04434-0. Epub 2019 Aug 10. Eur J Nucl Med Mol Imaging. 2019. PMID: 31399803 Free PMC article.
An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy.
Mease RC, Kang CM, Kumar V, Banerjee SR, Minn I, Brummet M, Gabrielson KL, Feng Y, Park A, Kiess AP, Sgouros G, Vaidyanathan G, Zalutsky MR, Pomper MG. Mease RC, et al. J Nucl Med. 2022 Feb;63(2):259-267. doi: 10.2967/jnumed.121.262098. Epub 2021 Jun 4. J Nucl Med. 2022. PMID: 34088772 Free PMC article.
Hetero-bivalent agents targeting FAP and PSMA.
Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR. Boinapally S, et al. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4369-4381. doi: 10.1007/s00259-022-05933-3. Epub 2022 Aug 15. Eur J Nucl Med Mol Imaging. 2022. PMID: 35965291
Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J, Beijer B, Bauder-Wüst U, Schäfer M, Leotta K, Eder M, Benešová M, Kleist C, Giesel F, Kratochwil C, Kopka K, Haberkorn U, Mier W. Carlos Dos Santos J, et al. J Nucl Med. 2020 Jan;61(1):70-79. doi: 10.2967/jnumed.119.229054. Epub 2019 Sep 20. J Nucl Med. 2020. PMID: 31541034 Free article.
143 results